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Abstract
Anesthesia for parturients with pulmonary arterial hypertension (PAH) is challenging. Successful management of anesthesia in
PAH parturients during labor requires an interdisciplinary approach and a multidisciplinary team. During parturition, neuraxial
anesthesia can be a safe and reasonable choice in this group of patients. Choosing the safest anesthesia method is always a challenge
in this scenario. In a case report study, the current researchers used management of anesthesia with neuraxial block and preserving
afterload and meticulous control of pulmonary hypertension.
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1. Introduction
Congenital heart diseases (CHDs) are one of the lead-
ing causes of cardiac diseases. Atrial septal defect (ASD)
is the second or third most common CHD in Iran (1, 2).
Pulmonary arterial hypertension (PAH) could be consid-
ered as primary or secondary to congenital or valvular
heart anomalies with age-related increase in its incidence
(3). Maternal mortalities are relatively high in pregnant fe-
males with pulmonary arterial hypertension despite avail-
able advanced therapies. According to the current guide-
lines, pregnancy is not recommended for this group of pa-
tients and early termination of pregnancy should be con-
sidered in pregnant females (4). Anesthesia management
is of paramount importance in these cases due to rapid
changes in cardiac parameters during anesthesia.
2. Case Presentation
The patient was a 30-year-old parturient with a history
of pulmonary arterial hypertension due to long-standing
congenital uncorrected atrial septal defect (ASD) admitted
due to the initiation of labor pain. In his past medical his-
tory, she also had asthma. In obstetric history, she had an
uneventful child birth by normal vaginal delivery five years
ago. During the preoperative visit, she was tachypnic with
a respiratory rate of 24 to 26 bpm. She also had tachycar-
dia with pulse rate of 138 bpm and blood pressure of 115/65
mmHg. Echocardiography was not performed due to pres-
ence of severe fetal distress, and the patient was prepared
for anesthesia without delay. The last echocardiography of
the patient one year ago indicated sinus venosus, mildly re-
duced systolic function of the left ventricle, left ventricu-
lar ejection fraction (LVEF) estimation of about 40%, basi-
lar and mid-inferoseptal hypokinesia of the LV, severely en-
larged RV (5.4 cm), mildly reduced function of the RV, di-
lated RA, trivial MR, no MS, normal structure and function
of AV, normal PV with mild PI and no PS, severe TR, no TS and
TR Gradient of 40 mmHg and finally PAP of 50 mmHg. Min-
imal pericardial infusion was also reported. The abnormal
laboratory finding was mild anemia (hemoglobin level of
11.4 g/dL and MCV of 79.9 fL). In prenatal screening ultra-
sound, neonatal cardiac evaluation was normal. Cardiol-
ogy consult recommended cesarean section and appropri-
ate prophylaxis of thrombosis.
In the operation room, 0.5 mg of midazolam was in-
jected intravenously as premedication due to maternal
anxiety. Preloading was accomplished by infusion of 500
mL of normal saline. Neuraxial anesthesia was selected as
the method of anesthesia for this patient because of in-
complete NPO time, bilateral widespread wheezes in both
lungs, lower respiratory tract infection symptoms, and
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anticipated difficult airway (short neck, micrognatia and
temporo-mandibular distance of about 4 cm). Spinal anes-
thesia was performed by mixture of 10 mg of hyperbaric
ropivacaine (5 mg/mL) solution and 25 µg of fentanyl ad-
ministered in the intrathecal space at L4 - 5 lumbar inter-
space level. Level of anesthesia was achieved and limited
to T6 by appropriate positioning. About five minutes after
skin incision, the baby was delivered with Apgar score of
10 in one and five minutes. The entire procedure was car-
ried out uneventfully in about half an hour. During anes-
thesia, standard monitoring of the patient was performed
using pulse oximetry for oxygen saturation (SPO2 percent-
age), noninvasive measurement of blood pressure, and 5
lead electrocardiogram (ECG). Supplemental oxygen was
delivered to the mother via a face mask in flow rate of 5
L/minute during the procedure. At the end of the opera-
tion, the mother was transferred to the intensive care unit
(ICU) and the newborn was admitted to the NICU. Postop-
erative analgesia for the mother was performed using ke-
tamine, administered via the PCA pump for the first post-
operative day. The mother and the baby were discharged
two days later with good condition and no incident during
the postoperative hospital stay. The patient and her fam-
ily were recommended to follow up proper evaluation and
treatment of her heart defect. Institutional review board
approval and informed patient consent was taken from
the patient for publishing the case for educational and re-
search purposes.
3. Discussion
Anesthesia in a parturient with uncorrected congen-
ital heart disease is always challenging. Pregnancy car-
ries additional risk of morbidity and mortality in these pa-
tients (4). Pulmonary arterial hypertension is associated
with a significant risk of maternal mortality during preg-
nancy and delivery and it is associated with significant risk
of maternal death. In this situation, cardiac function de-
pression leads to increased pulmonary vascular resistance
(5).
Atrial septal defect is often well tolerated during preg-
nancy (6). Pulmonary arterial hypertension induced by
ASD requires planning and meticulous measurements in
both regional and general anesthesia, and prevention of
incidental intravenous or epidural injection of air bub-
bles. Attenuation to hypotension following induction of
general anesthesia or sympathetic block by spinal anes-
thesia, which can lead to a decrease in systemic vascular
resistance and following reversal of shunt with maternal
hypoxemia, should be managed vigorously. Avoiding hy-
percarbia, acidosis, and pain, which could induce an in-
crease in pulmonary vascular resistance and shunt rever-
sal, should be considered during management of anesthe-
sia in this situation (6).
Management of anesthesia in obstetrics with pul-
monary arterial hypertension is another challenge to anes-
thesia, and severity of the disease is one of the most impor-
tant determinant factors. In such cases both general and
regional anesthesia have been performed successfully (5).
The main goal of anesthesia management in this group of
patients is avoiding desaturation and improving oxygena-
tion. This goal could be achieved by avoiding increase in
PVR and decrease in SVR. Oxygen supplementation could
help this goal. Sildenafil and prostacyclin are useful as pul-
monary vasodilator agents for controlling pulmonary ar-
terial pressure. Epidural anesthesia may be the preferred
method of neuraxial block in these patients and parturi-
ents because of better hemodynamic stability compared
to spinal block. However, spinal anesthesia, specially with
additives such as opioids or benzodiazepines, is another
attractive option for this purpose (7). In any neuraxial
anesthesia, the highest level of block maybe fixed at the
level of T6 for adequate anesthesia and avoidance of unsafe
hemodynamic instability. Close monitoring of patients’
hemodynamic status is the mainstay of this issue. For this
purpose, electrocardiogram, direct arterial blood pressure
and central venous pressure (CVP) monitoring, oxygen sat-
uration, right ventricular end-diastolic volume (RVEDV),
cardiac output, urinary volume, and arterial blood gas
analysis should be considered. Monitoring of pulmonary
arterial pressure by pulmonary arterial catheter is not rec-
ommended because of potential complications. Avoid-
ance of decreases in SVR or vigorous treatment of unfa-
vorable events by phenylephrine or noradrenaline should
be considered. Extracorporeal membrane oxygenation
(ECMO) could be a rescue treatment for refractory cases of
pulmonary hypertensive crisis. Limiting the administered
intravenous fluid is another key issue of anesthesia man-
agement in these parturients. Liberal fluid administration
can lead to heart failure and subsequent unwanted events.
For this reason, CVP or RVEDV monitoring would be benefi-
cial. Diuretics should be available for treating intravenous
fluid excess. Following delivery of the fetus, Esmarch rub-
ber bandages on the lower extremities could be used for
preventing unwanted increases of venous return that may
lead to heart failure. In addition, inotropic medications,
such as dopamine, should be available to treat heart fail-
ure (8, 9).
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General anesthesia is another yet unfavorable choice
for anesthesia management in parturients with PAH. This
method may be preferred in patients with greater illness.
If general anesthesia is inevitable, lung protective method
of ventilation is necessary for avoiding increases in PVR
(the patient should be ventilated with the lowest airway
pressure and tidal volume possible). Prevention of hyper-
carbia is another concern and should be managed in this
situation. Intravenous administration of catecholamines
should also be considered prior to induction of anesthesia
(9).
Oxytocin administration is another challenging issue
in anesthesia management for PAH parturients. Intra-
venous administration of this drug can lead to hypoten-
sion and therefore should be used cautiously and by slow
infusion (9, 10).
In conclusion, a multidisciplinary approach is re-
quired for successful management of anesthesia of ce-
sarean section in parturients with PAH, including attend-
ing team of anesthesiologists, obstetrics, neonatologists,
and pulmonary hypertension specialist, along with experi-
enced support staff (11). As it was described in this case, neu-
raxial anesthesia and meticulous control of pulmonary
and systemic blood pressure and rapid response to blood
pressure changes is vital for PAH parturient during ce-
sarean section.
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